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Abstract
Vitamin D deficiency, in an increasingly modernized world, is a major global health issue and so is major depressive disorder
(MDD) and its high fatality risk. Studies suggest that there may be a connection between the two. Several studies have
found a connection between low levels of vitamin D and higher rates of major depressive disorder, depressive symptoms
and suicidal ideation. Specifically, lower concentrations of vitamin D was seen in the subgroup of patients with suicidal
thoughts when comparing with non-suicidal depressed patients. A likely reason for this may be the well- researched role
vitamin D plays in regulation of inflammatory cytokine markers in the brain. Elevation of these proinflammatory cytokines
is shown to be a major contributing factor to depression and suicidality. Therefore, a lack of vitamin D contributes to an
increase in inflammation and thereby an increase in the risk of depression and suicide. Thus, increasing vitamin D levels
by supplementation or sun exposure, may decrease depressive symptoms. Because this research is recent, there are few
studies assessing the possible benefits and limitations of using vitamin D as a treatment method.
Introduction
Vitamin D₃ is a fat soluble vitamin, stored mainly in the liver
and adipose tissue. It is primarily obtained by the conversion of
cutaneous 7-dehydrocholesterol to previtamin D₃ by sunlight,
specifically Ultraviolet (UV) B radiation with a wavelength of
290–320 nanometers. Previtamin D₃ then spontaneously isomerizes to vitamin D₃, or cholecalciferol.Vitamin D3 is biologically
inert and must undergo two hydroxylation to be biologically
active. The first hydroxylation occurs in the liver, by 25-hydroxylase, converting vitamin D3 to calcidiol, or 25-hydroxyvitamin
D [25(OH)D]. The second hydroxylation occurs by 1α-hydroxylase, found primarily in the kidneys, although recent research
found this enzyme in many other tissues. The second hydroxylation converts the 25-hydroxyvitamin D to the biologically-useful calcitriol, or 1,25-dihydroxyvitamin D [1,25(OH)2D]
(Vitamin D: Fact, 2016).
Besides for obtaining vitamin D by sun exposure, vitamin D can be
obtained by food. However, very few foods in nature contain vitamin D.Therefore, a better way of obtaining vitamin D is from cholecalciferol-fortified foods or supplements (Vitamin D: Fact, 2016).
Serum concentration of 25-hydroxyvitamin D is the best indicator of vitamin D status, because it reflects vitamin D obtained
by sun exposure and ingestion. It also has a fairly long circulating
half-life of 15 days and its concentration is not affected by other
metabolites. However, it does not indicate how much vitamin
D is stored in body tissues. In contrast, 1,25-dihydroxyvitamin
D has a short circulating half-life of 15 hours and its levels are
closely regulated its own concentration and by hormones and
electrolytes like parathyroid hormone, calcium, and phosphate.
Additionally, levels of 1,25(OH)2D only decreases when vitamin
D deficiency is severe. Therefore, 25-hydroxyvitamin D levels
are used to assess sufficiency (Vitamin D: Fact, 2016).
There is considerable discussion of what serum concentrations
of 25-hydroxyvitamin D indicate vitamin D deficiency, adequacy
for bone health and optimal health overall. As of now, there
is no specific cut points established by a scientific consensus

process. However, the committee of the Institute of Medicine,
based on its review of data of vitamin D needs, have concluded
that there is a risk of vitamin D deficiency at serum 25(OH)
D levels of less than 30 nmol/L (<12 ng/mL). Additionally, some
people are potentially at risk for inadequacy at concentrations
ranging from 30-50 nmol/L (12–20 ng/mL). They stated that 50
nmol/L is the serum 25-hydroxyvitamin D level that is adequate
for 97.5% of the population. Only at concentrations of greater
than 125 nmol/L (>50 ng/mL) is there potential adverse effects
of overdose (Vitamin D: Fact, 2016).
Cutaneous vitamin D levels are mainly dependent on climate,
overall skin exposure, skin melanin content and age. Residing
in a climate closer to the equator results in more year-round
sun exposure and more vitamin D synthesis. Although surprisingly, geographic location does not consistently predict average
serum levels in a population. Opportunities exist to form vitamin D from exposure to sunlight during the spring, summer, and
fall months even in the far north or south, and it can be stored
in fat for periods of little sunlight. Darker skin absorbs less
sunlight and, therefore, more melanin reduces the production
of vitamin D. Perhaps, this characteristic may contribute to the
consistency in average serum levels of those near the equator
and those further away, because those who live near the equator generally have a darker skin tone that synthesis less vitamin
D than those farther away with a lighter skin tone. Vitamin
D synthesis may also decline with age because skin synthesis
declines (Johnson, 2016).
Major depressive disorder (MDD) is a common disorder and
leading source of disability worldwide. It is a major global health
problem, with more than 50% of all suicides contributed to
clinical depression (Bay-Richter, Janelidze, Hallberg, & Brundin,
2011). Classically, the prevailing hypothesis on the cause of major
depression was a deficiency of monoamines, a class of neurotransmitters and neuromodulators, like serotonin. Therefore,
current available medications for major depression mainly target monoamine pathways. However, research has not shown
a consistent relationship between serotonin and depression
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(Gardner & Boles, 2011). And although relatively affective, 30%
of depressed patients do not achieve remission even with multiple, monoamine-regulating, treatment trials (Miller, Maletic, &
Raison, 2009). Additionally, 50% to 80% of all patients treated for
major depression will experience relapse (Bay-Richter, Janelidze,
Hallberg, & Brundin, 2011). These monoamine regulating drugs
can have serious side effects, which include worsening of depressive symptoms and suicidal ideation. Therefore, it is imperative
to find novel pathways involved in depression and consequently
more effective treatments for those suffering.
Historically, in literature, and in art and religion, happiness and
positivity have been associated with summertime, daylight, and
sunny and open landscapes. In contrast, fear and gloom have
been associated with winter, night and dark and polluted urbanscapes. At the height of early industrialism, in such polluted
cities, rickets, which is extreme vitamin D deficiency was first
recognized. Among the symptoms of rickets, mental symptoms
were also described and Florence Nightingale stated: “People
say the effect [of sunlight] is on the mind. So it is, but the enlightened physician tells us it is on the body too.” (Humble, 2010)
Mental disturbances caused by reduced sun exposure seemed
self-evident that no one seemed to note the mental health benefits of rickets treatment, which was primarily to increase sun
exposure. Because of the awareness of adequate sun exposure,
rickets disappeared as a public health problem. Nevertheless,
from the 1950s and on, with increasing modernization, the time
spent indoors increased for all ages worldwide. Additionally,
since the 1980s, the public is being warned about the dangers of
UV rays and its contribution to malignant melanoma. Therefore,
people have developed concern of excessive sun exposure and
are applying sunscreen and covering up more when they are
outside. At the same time, as these changes are taking place, the
incidence of depression, especially in children and adolescents,
has become more and more prevalent in the United State and
Europe (Humble, 2010). Additionally, it is a long, well-known and
perplexing observation that death by suicide is highest in the
springtime for people living in temperate climates, which is also
when vitamin D levels are the lowest in the population (Umhau
et al., 2013). Is there a correlation between these two observed
phenomena of depression and vitamin D synthesis, and what
would be there relationship?

Materials and Methods
Materials for this comprehensive review were obtained from
Touro College’s online library, PubMed, PubMed central,
Proquest, National Institute of Health website and Merck
Manual website. The material consisted of clinical research papers, peer-reviewed journal articles and clinician-directed informational reports. The material was reviewed, critically analyzed
and compiled to answer research questions.
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Discussion
Vitamin D and Inflammation:
Classically, Vitamin D is associated with bone health. Vitamin
D aids calcium absorption in the gut and maintains adequate
serum calcium and phosphate levels for normal mineralization
of bone (Vitamin D: Fact, 2016). It is also needed by osteoblasts
and osteoclasts bone growth and repair. Vitamin D deficiency
was mostly associated with rickets and osteomalacia at extreme
deficiency. Rickets is a disease in children where vitamin D deficiency leads to bones not being able to properly mineralize,
which results in soft bones and skeletal deformities. In adults,
vitamin D deficiency can lead to osteomalacia, or weak bones
(Vitamin D: Fact, 2016).
Recently, many other functions of vitamin D have been discovered and vitamin D receptors have been found in many tissues.
One of the most significant findings is the function of vitamin
D in immune system modulation. There is an increasing number of studies that demonstrate the importance of vitamin D in
the reduction of inflammation and the association of vitamin D
deficiency with increased inflammation (Peterson & Heffernan,
2008). Most of the known effects of vitamin D are facilitated
through vitamin D receptors (VDR). These vitamin D receptors
have been found extensively in immune system cells, specifically
in T lymphocytes and macrophages. Furthermore, macrophages
have been found to express 1α-hydroxylase, which is the enzyme that is responsible for the final step in synthesizing biologically-active vitamin D. Additionally, they have been found to
express 24-hydroxylase, the major degrading enzyme of vitamin D. This means that these cells can regulate the production
and secretion of vitamin D in their own vicinity (Peterson &
Heffernan, 2008).
Additional evidence now suggests that vitamin D insufficiency
may play a role in immune system dysfunction and low 25-hydroxyvitamin D serum levels are shown to be associated with
autoimmune diseases like multiple sclerosis, Type 1 diabetes
and rheumatoid arthritis. Recently, this insufficiency has been
correlated to macrophage dysfunction, such as impaired chemotaxis, phagocytosis and increased production of proinflammatory cytokines. Proinflammatory cytokines are produced
predominantly by activated macrophages. These cytokines take
part in cell signaling and up-regulation of inflammatory reactions. Vitamin D has been shown to reduce inflammation by
down-regulating the expression of monocyte toll-like receptors
(TLRs), which are known to activate inflammation and aggravate
autoimmune disease and sepsis (Peterson & Heffernan, 2008).
In light of the research, Peterson and Heffernan (2008) sought
to investigate the relationship between serum vitamin D status
(25(OH)D) and inflammatory markers in 69 healthy women.
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They recruited people with high UVB and minimal UVB exposure, as assessed by a screening questionnaire, to obtain a
range of serum levels. Volunteers were excluded for multiple
factors, including, if they took a vitamin D supplement, had a
current or previous medical condition or took medication affected immune function. The results revealed that serum TNFα, a proinflammatory cytokine, was significantly lower in the
group of women with high UVB exposure, after controlling for
multiple factors. However, there was no significant statistical
difference shown between the two groups in regards to other
proinflammatory cytokines, like IL-10, CRP, IL-6. Serum TNF-α
concentrations are increased in several diseases like multiple
sclerosis, inflammatory bowel disease, rheumatoid arthritis,
heart disease and osteoporosis, and lowering TNF-α concentrations through sufficient vitamin D levels may improve disease
outcomes. The main limitation of this study was the small sample size. Additionally, women who frequently tan are characteristically different from non-tanners and may engage in behaviors
that can affect the study outcomes. This study shows a negative
correlation between vitamin D status and TNF-α concentration
in healthy individuals. More research is needed to determine if
vitamin D can be used as a therapy in inflammatory diseases.
A case where vitamin D deficiency seems to contribute to
immune modulation, is in diabetic foot infection. Diabetic foot
infection is a reflection of a diabetic patient’s altered immune
system. In an infectious state, pro-inflammatory cytokines are
released in the body, such as IL-1β, IL-6, interferon-γ (IFN-γ)
and TNF-α, or chemokines such as IL-8. To counteract these
factors and avoid a hyper-inflammatory state, the body releases
anti-inflammatory cytokines such as IL-10. In a diabetic patient,
several factors lead to decreased wound-healing abilities, including impaired cytokine production. This abnormal wound healing
is attributed to immune dysregulation because of vitamin D deficiency in addition to hyperglycemia (Timms et al., 2002).

correlated with IL-1β as well as IL-6 levels and moderately negatively correlated with TNF-α levels, but not correlated with
IFN-γ levels. In this study, diabetic patients with foot infection
serve as a model for immune system abnormality resulting from
hyperglycemia and infection, with increased pro-inflammatory cytokine concentrations. The results of the present study
showed that elevated cytokine responses occur as a factor of
vitamin D deficiency in patients with diabetic foot infection.
Vitamin D deficiency, particularly when serum levels were very
low, intensified inflammatory cytokine release in patients with
diabetic foot infection.
Because of this increasingly strong correlation and possibly
causation of vitamin D deficiency to amplified inflammation, and
to try to prove causation more visibly, Hoe et al. (2016) recently
performed a study ex vivo. They studied the effects of 1,25-dihydroxyvitamin D, the active metabolite of vitamin D, on peripheral blood mononuclear cells (PBMCs) and purified immune
cell subsets isolated from healthy patients, when they exposed
those cells to stimulation with Gram-positive heat-killed pneumococcal serotype 19F (HK19F) and Gram-negative Escherichia
Coli serotype 055:B5 derived lipopolysaccharide (LPS) bacterial
ligands. They found that in 1,25(OH)2D3 pretreated samples
compared to non-treated, for both ligands, 1,25(OH)2D3
suppressed proinflammatory cytokines, like TNF-α, IFN-γ and
IL-1β, and chemokine IL-8, in peripheral blood mononuclear
cells (PBMCs) and TNF-α and IL-1β in CD14+ Monocytes.
Anti-inflammatory IL-10 was increased in HK19F-stimulated
monocytes. Additionally, when comparing the blood samples of
the healthy subjects, they found that levels of HK19F-specific
IFN-γ were significantly higher in vitamin D-insufficient adults
(<50 nmol/L) compared to sufficient adults (>50 nmol/L). This
study suggests Vitamin D causes modulation of inflammation of
the immune system response which is critical for host defense.

Inflammation and Depression
Another study, investigating the relationship between vitamin D
deficiency and increased inflammatory cytokines, was done by
Timms et al. (2002), by evaluating the influence of vitamin D on
the concentrations of IL-1β, TNF-α, IFN-γ and IL-6 in patients
with diabetic foot infection. Subjects were 112 diabetic patients
with diabetic foot infection while 107 diabetic patients with no
evidence of infection served as controls, additionally, 40 healthy
subjects were included in the study. Vitamin D deficiency, a
serum 25-hydroxyvitamin D < 50 nmol/l, was found in 71.4% of
the diabetic foot infection patients, 61.6% of the diabetic controls and 48.6% of the healthy volunteers, but severe deficiency,
with a serum 25-hydroxyvitamin D of < 25 nmol/L, was mostly
found in diabetic foot infection patients than in diabetic controls
and healthy volunteers. In both patients and controls, 25-hydroxyvitamin D levels was found to be significantly negatively

The progression and complications of many diseases and disorders, like cardiovascular disease, diabetes and cancer, are being
increasingly attributed to inflammatory dysfunction. Additionally,
this theory of disorder is being extended to neuropsychiatric
disorders, with mounting evidence suggesting that defective alterations of the immune system seen in psychiatric patients may
contribute to their disorders, and with mounting evidence of
inflammation contributing to major depressive disorder. Patients
with major depression have been found to exhibit elevated
proinflammatory cytokines, like IL-1β, TNF-α and IL-6, which
have been shown to interact with areas known to be involved
in depression, including neurotransmitter metabolism, neuroendocrine function, and neural plasticity. Furthermore, psychosocial
stress, a common precipitator to major depression, has been
shown to have the ability to stimulate inflammation, owing to
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the fact that it activates sympathetic nervous system pathways.
Moreover, depressed patients with increased inflammatory markers have been found to have greater resistance to treatments, and
in studies, antidepressant drugs have been found to be correlated
with decreased inflammation (Miller, Maletic, & Raison, 2009).
Recurrent coinciding comorbidities and drug efficacies suggest
that depression is part of a group of related conditions, all of
which are associated with inflammation dysfunction. They are
sometimes referred to as the “affective spectrum disorders”,
and include migraine, irritable bowel syndrome, chronic fatigue
syndrome, fibromyalgia and generalized anxiety disorder, among
many others. Based on current knowledge, these diseases, including depression, seem to be a function of three connected
abnormalities: monoamine dysfunction, increased inflammation,
and mitochondrial disorder (Gardner & Boles, 2011)
To test if inflammation may correlate or even cause major
depression, several studies performed on animals who have
been injected with the endotoxin lipopolysaccharide (LPS) to
generate inflammation, showed that these subjects subsequently developed depressive-like symptoms. In clinical practice, it
has been seen that patients treated with interferons and interleukins, to promote inflammation against certain forms of
cancer and viral infections, like Hepatitis C, frequently develop
depression. To further investigate this relationship Bay-Richter,
Janelidze, Hallberg, & Brundin (2011) induced inflammation in
rats by administering Escherichia coli serotype 055:B5 lipopolysaccharides (LPS) intraperitoneally for four days.They measured
their levels of cytokine markers at the state of sickness and
then at the state of depressive-like behaviors. They also measured mRNA transcription of cytokines in specific brain areas
related to depression as well as levels of cytokines in serum
and cerebral spinal fluid. Cyclooxygenase enzymes, inflammatory stimulating COX-1 and COX-2, have previously been shown
to correlate with depressive-like behavior, thus, it is suggested
that proinflammatory cytokines can induce depressive-like behavior by activating prostaglandins, and inflammation, through
the cyclooxygenase enzyme. Therefore, they also measured cyclooxygenase enzymes in the brain of the mice. This is the first
published study examining the relationship between proinflammatory cytokines and cyclooxygenase enzymes in the blood,
CSF and depression-related brain areas and their capacity to
cause sickness and behavioral changes.
In this study, they found that there was a clear distinction between the phase of sickness, which is 2 hours after injection
of lipopolysaccharides, and the phase of depressive symptoms,
which is 24 hours after injection, for cytokines, cyclooxygenase
enzymes and mRNA transcription of cytokines. During the sickness behavior, IL-1β and IL-6 were elevated in the blood, IL-1β
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was elevated in the CSF, and TNF-α was elevated in the striatum
of the brain. Also, IL-1β mRNA transcript was increased in the
frontal cortex and hippocampus. Curiously, in this phase, IL-6
and COX enzymes were decreased in the hippocampus. After
24 hours of injection, the rats did not show signs of sickness but
began displaying depressive symptoms in the forced swim test.
This test is used on rodents to evaluate depression and is used
when assessing antidepressant drugs and therapies. During the
depressive phase of behaviors, the transcription of TNF-α mRNA,
IL-6 levels and COX enzymes levels shifted back to normal levels in all brain areas, but the cytokine IL-1β was still significantly
elevated in the frontal cortex and hippocampus and there was
an increase in the concentration of IL-1β in the cerebral spinal
fluid. This increase was only found in the CSF and not in blood
serum.This may explain why studies measuring the serum level of
cytokines in patients with major depressive disorder, did not find
any significant difference when comparing depression levels with
normal levels. In this study, they found that Lipopolysaccharideinduced depression is primarily associated with the increase of
IL-1β. This cytokine remains elevated in the brain even after the
initial inflammatory phase and continues to contribute to a depressive-like phenotype in the rats.This suggests that a short term
immune inflammatory response may lead to long term changes
in transcription of inflammatory markers and that transcription
levels may even increase after the initial immune response (BayRichter, Janelidze, Hallberg, & Brundin, 2011).
Although, elevated inflammatory markers are found in many patients with psychiatric disorders, there is no clear differentiation
or explanation why some patients have elevated cytokine concentrations and some do not. Perhaps, there is a specific subgroup
of patients that will display signs of inflammation. To advance and
investigate if the phenomenon of increase cytokine concentrations in psychiatric patients is specific to a subgroup of depressed
patients, Janelidze, Mattei, Westrin, Traskman-Bendz, & Brundin
(2011) designed a study dividing their subjects by non-suicidal
and suicidal patients. In this study, they compared plasma cytokine
levels in 47 treated and untreated patients with depression that
had attempted suicide, 17 untreated patients with a diagnosis of
major depressive disorder that did not have any suicidal ideation
and 16 somatically healthy controls with no current or previous
history of neuropsychiatric disorder. They found statistically significant elevated plasma concentration of proinflammatory cytokines IL-6 and TNF-α and decreased plasma concentrations of
anti-inflammatory cytokine IL-2 in the suicide attempters, compared to the non-suicidal depressed patients and healthy controls. Elevated cytokines were seen in suicidal patients, regardless
if they had received treatment or not. Although a limitation of
this study is that the duration of the disorder and duration of
treatment were not considered. Interestingly, these patients with
elevated cytokines did not show any signs of systemic or local
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infection or inflammation.This suggests that inflammation seen in
depressed patients is specific to those that are suicidal, although
it may also be specific to different subgroups of depression too.
Furthermore, it suggests that these elevations are associated
and may contribute to suicidal ideation. Because this study used
patients with untreated major depression, one group it did not
control for specifically, is patients with treatment-resistant depression, and therefore, perhaps increased cytokines is seen in all
patients with treatment-resistant depression, not only those who
have attempted suicide. Evidence of abnormal cytokine elevations
were observed in suicidal patients, compared to non-suicidal
depressed patients and healthy controls, and may contribute to
suicidality.

fluctuation and its neuropsychiatric effects. In summation,
Lindqvist et al. found that inflammatory cytokines were directly
correlated with the presence and extent of suicidal thought and
behavior and the degree of violence of a suicide attempt.

As the mechanism that causes depression and suicide is located in the brain, it is important to understand if these systemic
inflammatory changes relate to changes in the central nervous
system. Lindqvist et al. (2009) tested the proinflammatory cytokine profile of the cerebral spinal fluid (CSF) of 63 institutionalized patients who had recently attempted suicide compared to healthy controls. They also evaluated if there was a
difference in the cytokine profile of patients who had attempt a
violent method of suicide compared to the patients who used
a nonviolent method. The patients underwent a “wash-out”
period where they discontinued all antidepressant and antipsychotic medication until there was no trace of it in their blood.
Depressive symptoms were assessed using the MontgomeryÅsberg Depression Rating Scale (MADRS) and suicidal ideation
was assessed using the Suicide Assessment Scale (SUAS). They
found that the patients who had attempted suicide had higher
levels of cytokine IL-6 in their cerebral spinal fluid to healthy
patients, and the violent suicide attempters had the highest concentration of IL-6. They also found that CSF IL-6 had a positive
correlation with intensity of depressive symptoms in all suicidal patients. Additionally, they found that IL-6 levels correlated
positively with current suicidal ideation and suicidal symptoms,
as in patients expressing a “wish to die” and “preoccupation
with suicidal thoughts.” These results suggest that, as discussed
previously, IL-6 may have specific relevance to suicide. They did
not find any significant difference in proinflammatory cytokine
IL-1β, TNF-α, and IL-8 between the groups studied. Lindqvist et
al. then went further to try to determine a mechanism of how
these abnormalities may contribute to suicidality. They compared levels of cytokines with known biomarkers of depression
and suicide and found that both IL-6 and TNF-α was related to
increased levels of 5-HIAA, which is a metabolite of serotonin,
and HVA, which is a metabolite of dopamine, in the fluid of the
patients who attempted violent suicide methods. This suggests
that proinflammatory cytokines may modulate monoamines in
the central nervous system. Further, longitudinal studies would
be helpful in studying the effects of cytokine and monoamine

The presence of vitamin D receptors (VDR), in the central nervous system was first discovered in 1982 by Stumpf, Sar, Clark,
and DeLuca. And nowadays, there is significant evidence of vitamin D’s presence and actions on different parts of the brain
and nervous system functioning. There is increasing evidence
that the vitamin D receptor (VDR) mediates transcription of
more than 1,000 genes (Umhau et al., 2013). Calcitriol is known
to function in the regulation of neurotransmitters, specifically
dopamine, adrenaline, noradrenaline and acetylcholine, regulates
several neurotrophic factors of the central nervous system, by
enhancing nerve growth factor (NGF) and glial derived neurotrophic factor (GDNF), and assist with anti-oxidative properties
in the brain (Humble, 2010). Many of the effects that vitamin D
has on the brain, share pathways with factors, when abnormal,
are known to be associated with several neuropsychiatric disorders including major depressive disorder (Humble, 2010). Based
on this, inadequate levels of vitamin D may lead to changes in
the central nervous system that may interfere with brain function and contribute to mood disorders.

Vitamin D and Depression
As discussed previously, there is strong evidence that vitamin
D deficiency may be contribute and cause immune system dysfunction, including elevated inflammatory markers. And elevated
inflammatory markers may play a role in depression with suicidal ideation. Therefore, there are many that suggest that vitamin
D deficiency may be a contributing factor in those who suffer
from suicidal thoughts accompanying major depressive disorder.

As depression is underdiagnosed in non-institutionalized healthy
populations and subclinical depression and chronic low mood is
common in older adults, and is a factor in morbidity, mortality
and quality of life, one study seeking to clarify if vitamin D may be
associated with depression in healthy adults was done by Lee et
al. (2011). Lee et al. used baseline data from the European Male
Ageing Study (EMAS), a cohort study of male aging in Europe, to
determine whether concentrations of serum 25-hydroxyvitamin
D were associated with levels of depression in a large sample
size of 3151 subjects, well-characterized, community-dwelling
sample of middle-aged and older men with a mean age 60 ± 11.
Subjects were assessed on social issues, lifestyle behaviors, and
any related comorbidities, like heart conditions, pituitary disease, diabetes, and cancer. Depressive symptoms were assessed
using the Beck Depression Inventory-II (BDI-II). Their results
found that serum vitamin D concentrations were significantly
lower in men with depressive symptoms, scoring ≥14 on the
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BDI-II, 10 nmol/L decrease in 25-hydroxyvitamin D was associated with an average increase of 5.2% in the BDI-II score. Even
after adjusting for age, smoking, alcohol consumption, physical
activity, BMI, comorbidities and adverse life events, there was
still a significant difference in serum vitamin levels. Additional
adjustment for season did not change this inverse association.
Only 22 men (0.7%) reported taking vitamin D supplements and
exclusion of these men did not change the results. A major limitation of this study, is its difficulty in assessing causality or even
if vitamin D contributes to depression. It may be that vitamin D
insufficiency may just be a ‘risk marker’ of general poor health
and lifestyle. Depressive behaviors of decreased physical activity
and exposure to sunlight may by itself lead to lower vitamin D
levels. Lee et al. did attempt to adjust for this factor by assessing
if physical activity can contribute to low vitamin D levels but
this adjustment does not measure sunlight exposure or rule out
reverse causality. The main strengths of this study is their large
sample size of healthy subjects of similar origin and uniform
methods of assessing depressive symptoms. Their study did find
an inverse relationship between serum vitamin D levels and depressive symptoms, mostly independent of confounding factors.
To further this relationship and see if low vitamin D levels is a
conclusively a predisposing factor of suicide, Umhau et al. (2013),
did a case-control study of 25-hydroxyvitamin D concentration,
of serum samples stored in the Department of Defense Serum
Repository, of deployed active-duty service members who had
subsequently committed suicide. 495 subjects were selected
from the Armed Forces Health Surveillance Center (AFHSC)
who had officially verified suicides occurring between 2002
and 2008 and had blood sampled within 24 months of death.
Controls were randomly selected from the same data bank, and
were matched as taking the blood work within 12 months of
those who had committed suicide, to minimize for any temporal changes in military environment. They found an increased
risk of suicide in lower levels of serum 25-hydroxyvitamin D,
and all those who committed suicide has a seasonally adjusted
levels below 20 ng/mL. Additionally, they found that 30% of the
suicides assessed occurred in those in the lowest levels of vitamin D status. When they graphed the data, they found a curve
that is characteristic of nutritional intake, which appears to have
benefit until a threshold is reached and after that, any additional
enrichment shows little benefit. Meaning, that if sufficient nutrient input is reached then further input will have no effect
on outcomes. Which is important when considering Vitamin
D supplementation as a treatment method, as discussed later.
One limitation of this study, is that vitamin D levels were not
measured at the time of suicide but sometimes months before.
This problem is lessened by the fact that vitamin D levels are
shown to be correlated up to 3 years apart. Perhaps, active-duty service members may have a higher risk of suicide because
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they often work at night and are excessively covered up in the
daytime, therefore, their reduced sun exposure and subsequent
reduced vitamin D synthesis contributes to their suicidality. In
this study, vitamin D status before suicide attempt was inversely
correlated with suicide risk in a large sample size of a specific
subset of the population with a general high risk of suicide.
Suicidal ideation may be sudden and in most cases, the first
thoughts of suicide often occur less than 10 minutes before the
suicide attempt. In a young, and somewhat aggressive, population like military service members, impulsivity may contribute
to their risk of suicide. There seems to be a link between vitamin D and impulsivity, as vitamin D increases proinflammatory
cytokines in the brain. Proinflammatory cytokines reduces serotonin activity which is long associated with impulsive suicide
(Umhau et al.,2013). As discussed in detail earlier, perhaps, this
effect of vitamin D is the mechanism by which vitamin D deficiency contributes to higher suicide rates.
Is present vitamin D concentration associated with suicide attempt? As a similarly designed study discussed previously, done
by Janelidze, Mattei, Westrin, Traskman-Bendz, & Brundin (2011)
to show that increased inflammatory cytokine concentration
of IL-6 and TNF-α contributes to suicide risk, Grudet, Malm,
Westrin, & Brundin (2014), takes it a step further, to see if vitamin D concentrations, which also contributes to increased
inflammatory cytokine concentrations, differ in suicidal depressed patients compared to non-suicidal depressed patients.
They included a total of 59 patients who had attempted suicide,
and had two control groups of 17 untreated patients with major
depressive disorder who had no suicidal ideation and 14 somatically and psychiatrically healthy patients.They found a significant
difference in serum 25-hydroxyvitamin D levels between groups,
with the suicide attempters have a significantly lower mean vitamin D concentration, of 47 ± 20 nmol/L, than the non-suicidal
patients, 62 ± 27 nmol/L, and healthy patients, 65 ± 26 nmol/L.
Additionally, 58% of patients in the suicidal group had a clinical
vitamin D deficiency of below 50 nmol/L, compared to 30% in
the other two control groups.When comparing vitamin D levels
and inflammatory cytokines in all groups, they found a correlation between 25-hydroxyvitamin D serum concentrations and
proinflammatory cytokine serum concentration of IL-1β. They
did not find a statistically significant correlation between vitamin
D and cytokines IL-6 and TNF-α in all groups. When comparing
individual groups, they found an inverse association between
25-hydroxyvitamin D and IL-1β in the patients who attempted
suicide and an inverse association between 25-hydroxyvitamin
D and IL-6 in the non-suicidal depressed patients. In conclusion,
they found a negative correlation between vitamin D levels and
suicide risk and a negative correlation between vitamin D levels
and proinflammatory cytokines. The cross-sectional design of
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this study does not allow any conclusions whether low vitamin
D status can be a direct contributing factor of suicide, but based
on previous knowledge of the mechanism of 1,25-dihyroxyvitamin D on brain function and regulation, there is considerable
evidence to suggest a direct causality.
Vitamin D deficiency is common in the modern world and
Vitamin D supplementation is relatively inexpensive nutritional
additive. If this vitamin D insufficiency has a direct contribution
on depression and suicide, can vitamin D be used a treatment
to reduce depressive symptoms and stop the epidemic of depression and suicide worldwide?
As a vitamin D intake is an easy nutritional therapy, BertoneJohnson et al. (2011) seeks to clarify if vitamin D supplementation can prevent or treat depression. They patients used for
this study were part of a large and diverse sample size that
was tracked for a long period of time. The subjects used for
this study were part of the observation study (OS) component of the Women’s Health Initiative (WHI) This is a database
composed by the National Institute of Health which allowed
Bertone-Johnson et al. to follow the health of 81,189 postmenopausal women over an 8-year period. Baseline intake was
assessed by asking patients about diet and any vitamin D supplementation and estimates of total solar irradiance was calculated based on the geographic location of the clinic centers
and controlled when interpreting the results. At each clinic
visit, depressive symptoms were assessed using the Burnam
8-item scale for depressive disorders. When controlling for
confounding factors, they found that lower vitamin D intake
of <100 IU/day had a strong inverse correlation in women
who met criteria for prevailing depressive symptoms at the
baseline visit. And the reverse was also true, those patients
with a substantial intake of vitamin D was associated with a
lower prevalence of depressive symptoms. This effect seemed
to have a threshold, as those positive effects of increased intake was only shown in patients who consumed 400 to <800
IU/day and an intake of ≥800 IU/day was not associated with
decreased risk of depression. At year 3 of the study increased
vitamin D intake was correlated with lower risk of depressive
symptoms in patients with no evidence of depression at baseline. A limitation of this study, is that it did not measure serum
25-hydroxyvitamin D levels in conjunction with intake levels.
This is important as the effects of vitamin D intake on serum
vitamin D levels may differ in individuals. Individuals may differ
in the processing of vitamin D ingestion; these differences are
in part because of genetic factors, vitamin D metabolism and
general dietary intake. This study saw an inverse relationship
between vitamin D intake and depressive symptoms in older
women.

One study, looking at the direct effects of vitamin D supplementation on depressive symptoms in conjunction with metabolic profiles, c-reactive protein (CRP), an inflammatory marker,
and oxidative stress. Sepehrmanesh et al., (2016) performed a
randomized, double-blind, clinical trial in performed in Kashan,
Iran, from October 2014 to December 2014. They included 36
patients, ages 18–65 years, equal parts men and women, diagnosed with major depressive disorder and randomly assigned
18 of them to receive a single capsule of 50,000 IU vitamin D
weekly and 18 patients to receive a placebo weekly for 8 weeks
in total. The Beck Depression Inventory (BDI) was used to assess depressive symptoms before and after supplementation. As
expected, after 8 weeks, changes in vitamin D concentrations
were greater in the vitamin D group than in the placebo group.
The group taking vitamin D supplements had improved insulin
function and decreased oxidative stress than the patients that
took a placebo. No changes were seen in c-reactive protein levels between both groups. This may be because of the duration
of the study or the specific inflammatory marker studied, as different inflammatory markers have been found to be associated
with vitamin D deficiency and depression. But most importantly,
this study found that the patients taking vitamin D supplements
had significant decreased depressive symptoms, and decreased
BDI total scores, post-nutritional therapy compared to before.
As all these patients had vitamin D deficiency of less than 20
μg/L at the start of this study, it is not possible to assess if the
effects of supplementation are seen only in vitamin D deficient
individuals or this therapy may also be useful in those who have
clinically sufficient levels of vitamin D. Perhaps the beneficial effects of supplementation can be explained by the fact that both
groups had a low baseline mean serum 25-hydroxyvitamin D
level. Therefore, a relatively short supplementation period was
effective in lowering depressive symptoms. Overall, vitamin D
supplementation had a positive effect on lowering depressive
symptoms in patients with major depressive disorder.

Conclusion
Vitamin D status seems to be directly linked to mood disorders and particularly major depression. A mechanism for this
association is demonstrated in detail, as both are correlated
to inflammatory cytokine status. Vitamin D deficiency is associated with an elevation of proinflammatory cytokines because
vitamin D modulates and prevents uncontrolled inflammation
systemically and in the central nervous system. This elevation of
proinflammatory cytokines may have adverse psychiatric effects.
It can contribute to depressive symptoms and even suicide.
Patients with suicidal thoughts specifically, seem to have abnormal proinflammatory cytokines and lower levels of vitamin D in
their body, than patients with major depression that do not have
suicidal thoughts.
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As the conceptual understanding of vitamin D’s activity as a
neuro and immune modulator on the brain is an innovative and
relatively new area of study, there are few direct-link studies on
how the supplementation of vitamin D may reduce instances of
major depressive disorder and suicide risk. Vitamin D supplementation treatment for major depressive disorder should be
tested in a larger sample size, in patients with clinically sufficient
vitamin D status, and for longer periods of time.Additionally, this
treatment should be tested in patients with suicidal ideation, as
this is the subgroup that has been differentiated to be effected most by vitamin D deficiency. Furthermore, studies should
assess the difference between treatments that raise vitamin D
levels by intake versus UV ray exposure. Perhaps, vitamin D status and its effects may differ when synthesized naturally in the
skin with direct access to subcutaneous fat for storage and the
bloodstream, in contrast the supplementation being first processed in the gastrointestinal tract. Vitamin D as a treatment
method for major depressive disorder is a new and exciting area
of research that may impact the global population tremendously due to the large number of people suffering of depression
worldwide. More research on the effectiveness and limitations
of this treatment should be done to maximize its impact.
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